(Q45855157)

17 December 2017

title

Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. (English)

1 reference

17 December 2017

5

U Seligsohn

1 reference

17 December 2017

author name string

T Livnat

1

1 reference

17 December 2017

A Zivelin

2

1 reference

17 December 2017

U Martinowitz

3

1 reference

17 December 2017

O Salomon

4

1 reference

17 December 2017

publication date

1 January 2006

1 reference

17 December 2017

Journal of Thrombosis and Haemostasis

published in

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

192-200

1 reference

17 December 2017

Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Mechanism of factor VIIa-dependent coagulation in hemophilia blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

How factor VIIa works in hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Platelet activity of high-dose factor VIIa is independent of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Recombinant human factor VIIa (rFVIIa) can activate factor FIX on activated platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Blood-borne tissue factor: another view of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Mechanism by which recombinant factor VIIa shortens the aPTT: activation of factor X in the absence of tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

What dose of recombinant activated factor VII should be used in patients with factor XI deficiency?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01683.X

10.1111/J.1538-7836.2005.01683.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017